1:21-cv-01784 Janssen Pharmaceuticals, Inc., et al. v. Tolmar, Inc.
USCA Mandate ( 208
The US Court of Appeals for the Federal Circuit issued a mandate in Janssen Pharmaceuticals, Inc. v. Tolmar, Inc., effectively ending the appeal process. This mandate was issued in response to a previous ruling. The case involved a dispute between Janssen Pharmaceuticals and Tolmar, Inc. over a patent.
No timeline activity recorded yet. This page will grow as rulings and filings land.
Court
D. Del.
District of Delaware · 3rd Circuit · DE
Docket
Not captured
Civil
Stage
Active litigation
Active
Filed
Date unavailable
Not in the available feed
Latest Filing
1:21-cv-01784 Janssen Pharmaceuticals, Inc., et al. v. Tolmar, Inc.
Other · May 05, 2026
Coverage
1 article
1 source tracked
Participants
1 Plaintiff
2 linked entities
Judge
Not assigned in feed
This case is tied to District of Delaware, a federal district court in DE.
The newest docket activity we have is a other dated May 05, 2026.
The visible party/entity graph currently includes 1:21-cv-01784 Janssen Pharmaceuticals, Inc and others.
Press monitoring has found 1 related article from 1 distinct source.
District of Delaware (D. Del.) is a federal district court in the 3rd Circuit, DE.
The US Court of Appeals for the Federal Circuit issued a mandate in Janssen Pharmaceuticals, Inc. v. Tolmar, Inc., effectively ending the appeal process. This mandate was issued in response to a previous ruling. The case involved a dispute between Janssen Pharmaceuticals and Tolmar, Inc. over a patent.
USCA Mandate ( 208
Sources tracked
1 outlet · 1 article
Timeline events
1 record on file
Last updated
1 day, 2 hours ago
Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.